We don't want you to just wait for people to come to you
In Ireland, the boundary between healthcare and the places people actually live has quietly shifted. Health Minister Stephen Donnelly has authorized pharmacists to carry flu vaccines beyond their shop doors — into homes, cars, and community spaces — recognizing that for the most vulnerable, the distance to a pharmacy can be the difference between protection and exposure. The decision, arriving as winter and a pandemic converge, reflects an older truth in public health: a remedy only reaches its full power when it travels to meet the people who need it most.
- With Covid-19 still circulating and winter approaching, Ireland faces the dangerous overlap of two respiratory threats at once.
- Years of bureaucratic constraint had kept pharmacists tethered to their counters, leaving vulnerable people — the housebound, the frail, the carless — underserved by existing vaccination infrastructure.
- A legislative amendment now frees pharmacists to vaccinate in homes, cars, and off-site clinics, backed by financial incentives of €15 per jab and €100 per ten vaccinations to drive community outreach.
- The Irish Pharmacy Union, after years of advocacy, calls the change a game changer — pharmacists are already envisioning clinics in care homes and community centers.
- Ireland's government is explicitly aiming for its largest flu vaccination programme ever, shifting the burden of access from patient to provider.
Ireland's Health Minister Stephen Donnelly has redrawn the map of preventive medicine with a legislative amendment allowing pharmacists to administer flu vaccines outside their premises — in people's homes, in cars, wherever the need exists. The change arrived at a moment of particular urgency: Covid-19 was still circulating, winter was closing in, and the prospect of a dual respiratory threat made expanding vaccination reach feel less like a policy option and more like a necessity.
The Irish Pharmacy Union, which had spent years pressing for this flexibility, welcomed the move as a game changer. Secretary General Darragh O'Loughlin argued that broadening vaccination locations would meaningfully increase uptake and help build population immunity. The government reinforced the ambition with financial incentives — €15 per vaccination and an additional €100 for every ten administered — designed to pull pharmacists out of their shops and into the community.
Donnelly was candid about the philosophy behind the decision. Rather than expecting vulnerable people to navigate their way to a pharmacy or GP surgery, he wanted providers to go out and find them. The burden of access, he made clear, should rest with the system, not the patient.
The move formalized something pharmacists had already been imagining: vaccination clinics in care homes, community centers, and the driveways of people who struggle to travel. Trusted and embedded in their communities, pharmacists were ready to serve as a frontline of preventive care. The legislation gave them the permission to act on it.
Ireland's Health Minister Stephen Donnelly has rewritten the rules for how flu vaccines reach people. Starting now, pharmacists can administer shots outside their shops—in homes, in cars, wherever the vulnerable need them. The move came as a legislative amendment, one that Donnelly framed not as a minor adjustment but as a fundamental shift in how the state approaches preventive medicine.
The Irish Pharmacy Union, which has spent years pushing for this authority, called it a game changer. Darragh O'Loughlin, the union's secretary general, noted that pharmacies had been requesting this flexibility for years. The timing felt urgent. Winter was coming, and Covid-19 was still circulating. A dual threat—flu and pandemic—made the calculus simple: get more people vaccinated, faster, by removing the friction of location.
Donnelly's language revealed the ambition behind the decision. "We want this to be the biggest flu vaccination programme the State has ever seen," he told reporters. To make it happen, the government structured financial incentives that rewarded reach. Pharmacists would receive €15 for each jab administered, plus an additional €100 for every ten people vaccinated. The math was designed to push pharmacists out of their shops and into the community.
The minister was explicit about what he wanted to change. Rather than waiting for people to come to them—to walk into a pharmacy or a GP surgery—he wanted pharmacists to go out and find the people who needed protection most. "We don't want you to just wait in your pharmacy or in your GP practice for people to come in to you," Donnelly said. The burden of access would shift from the patient to the provider.
O'Loughlin framed the expansion in terms of public health necessity. Broadening the locations where pharmacists could vaccinate would significantly increase uptake, he argued, and help build immunity across the population. The Irish health system had learned from years of managing preventable disease: reach matters as much as availability. A vaccine sitting in a pharmacy does no good if the person who needs it most never walks through the door.
The decision reflected a broader recognition that pharmacists, already embedded in communities and trusted by patients, could serve as a frontline of preventive care. They were not waiting for permission to innovate—they were already thinking about how to reach vulnerable groups. The government's move simply formalized what pharmacists had already begun to imagine: vaccination clinics in community centers, in care homes, in the cars of people who couldn't easily travel. The legislation was the permission slip; the pharmacists would do the work.
Notable Quotes
We want this to be the biggest flu vaccination programme the State has ever seen. We are incentivising pharmacists to go out there, set up off-site clinics and reach vulnerable groups.— Health Minister Stephen Donnelly
Broadening the locations where pharmacists can vaccinate will significantly increase uptake and will help build immunity from flu among the population.— Darragh O'Loughlin, Irish Pharmacy Union secretary general
The Hearth Conversation Another angle on the story
Why did the government decide to do this now, in October 2020 specifically?
The timing was about dual threats. Covid-19 was still spreading, and winter flu season was arriving. The health system couldn't afford to have flu cases pile on top of pandemic cases. Pharmacists had been asking for this for years, but the crisis made it urgent.
So the money—€15 per jab plus €100 per ten people—that's meant to incentivize them to actually go out and find people?
Exactly. It's not just payment for work; it's a signal about what the government values. The bonus structure rewards volume and reach. A pharmacist who sets up a clinic in a nursing home or a community center gets paid more than one who just waits in the shop.
What makes this a "game changer" in the union's eyes?
For years, pharmacists were confined to their premises. They could see the people who came to them, but not the people who couldn't come—the elderly, the housebound, the isolated. Now they can go to those people. That's a fundamental change in how healthcare gets delivered.
Is there a risk that pharmacists spread themselves too thin, trying to cover too much ground?
That's a real question, but the union seems confident they can manage it. The incentive structure helps—it rewards them for the effort. And remember, this is about reaching vulnerable groups specifically. It's targeted, not a free-for-all.
What happens if this works? Does it change how other vaccines or preventive care gets delivered?
That's the forward question. If pharmacists can successfully vaccinate people in their homes during a flu season, why not other vaccines? Why not other preventive services? This decision could reshape what community pharmacy looks like.